SP346RESPONSIVENESS TO ERYTHROPOIESIS-STIMULATING AGENTS IN PREVALENT HEMODIALYSIS PATIENTS WITH CANCER; MULTICENTER SURVEILLANCE IN JAPAN
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details